Formats

The synthesis: a format governs dose consistency and pharmacokinetics, never efficacy. Choosing a container cannot answer whether microdosing works.

Why an inconsistent dose makes any microdosing evaluation unreadable. Consistency is a precondition for studying an effect, not proof that one exists.

A claims map for formats: best format, potentiates, lab-tested means effective, format sequencing — each matched to the evidence question it quietly skips.

The psilocybin-to-psilocin conversion behind lemon tek is a mechanism, not a measured microdose result. The faster and stronger claims are largely uncontrolled.

Why a botanical with variable alkaloid content resists standardization, what bioequivalence and bioavailability mean as concepts, and why trials go synthetic.

Tinctures, gummies, and chocolates promise better absorption or skipped digestion. That is pharmacokinetic plausibility, not a demonstrated microdose benefit.

A dosage form can shift the pharmacokinetics of psilocybin — rate and extent of absorption — but it cannot create, validate, or enlarge a microdose effect.

Whole dried material versus capsules examined as a measurement tradeoff and a preference report — not a recommendation, and with no weights, scales, or increments.